[Diagnosis and management of necrotizing otitis externa].

Verena Strasser, Lea Stecher, Gerlig Widann, Teresa Steinbichler

Abstract readReviewEnglish Abstract

In one paragraph

Review in HNO, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Verena StrasserUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich.

Lea StecherUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich. lea.stecher@tirol-kliniken.at.

Gerlig WidannUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich.

Teresa SteinbichlerUniversitätsklinik für Hals‑, Nasen- und Ohrenheilkunde, Medizinische Universität Innsbruck, Anichstr. 35, 6020, Innsbruck, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Necrotizing otitis externa (NOE) is a rare, potentially life-threatening invasive infection of the external auditory canal that predominantly affects elderly and immunocompromised individuals-particularly those with diabetes mellitus. The disease may progress to skull base osteomyelitis and can lead to severe complications such as cranial nerve palsy, meningitis, or dural sinus thrombosis. The most common causative pathogen is Pseudomonas aeruginosa, although invasive fungal infections are increasingly recognized. The primary therapeutic strategy involves extended administration of pathogen-specific systemic antimicrobial agents. Surgical intervention may be required for complicated clinical courses. For monitoring disease progression and evaluating the therapeutic response, fluorodeoxyglucose positron-emission tomography (18F-FDG-PET) in combination with computed tomography (CT) or magnetic resonance imaging (MRI) of the temporal bone has proven valuable. Lifelong closeknit otolaryngological follow-up is essential to detect recurrences early.

Indexed as

Anti-Bacterial AgentsOtitis ExternaCombined Modality TherapyHumansNecrosisTreatment OutcomeAnti-Bacterial AgentsCranial nerve diseasesDiabetes mellitusOsteomyelitisPositron-emission tomographyPseudomonas aeruginosa

Identifiers

PMID41384951

DOI10.1007/s00106-025-01690-5

PMCPMC12855364

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.